Study summary
An old heart drug, digitoxin, lowered death or hospital stays
39.5%died or were hospitalized for heart failure, vs 44.1% with placebo
What was tested
Digitoxin, a digitalis drug, or placebo added to modern treatment in heart failure with reduced ejection fraction and significant symptoms.
What they found
- Death or first heart failure hospitalization: 39.5% vs 44.1% over 36 months.
- Serious side effects were 4.7% vs 2.8%.
What it means
A cheap, once-daily add-on for people still symptomatic on standard drugs.
Last reviewed 2026-11-16 by the Find a Trial editorial team.
Information on this page is for educational purposes and is not medical advice.
Always consult qualified healthcare professionals about clinical trial participation.